Manufacturing Considerations of mRNA- Based Therapeutics
Time: 12:15 pm
day: Day One
Details:
- New API modalities require new manufacturing processes
- The optimal mRNA processes may depend on the application – for example, a pandemic vaccine versus a personalized therapy
- Fibro-based chromatography for large target molecules can boost productivity
